TickerFactsScreenerDevelopers

Actinium Pharmaceuticals, Inc. (ATNM) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2009: $2.1K2010: $196.1K2011: $5.70M2012: $5.62M2013: $5.53M2014: $6.71M2015: $25.64M2016: $20.52M2017: $17.40M2018: $13.67M2019: $9.25M2020: $63.56M2021: $77.83M2022: $108.91M2023: $76.68M2024: $72.90M2025: $48.00M$48.00M
2009Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$48.00M-34.2%
2024$72.90M-4.9%
2023$76.68M-29.6%
2022$108.91M+39.9%
2021$77.83M+22.4%
2020$63.56M+586.8%
2019$9.25M-32.3%
2018$13.67M-21.4%
2017$17.40M-15.2%
2016$20.52M-20.0%
2015$25.64M+282.3%
2014$6.71M+21.2%
2013$5.53M-1.5%
2012$5.62M-1.5%
2011$5.70M+2808.1%
2010$196.1K+9142.9%
2009$2.1K—